CTOs on the Move

Implanet

www.implanet.com

 
Founded in 2007 and based near Bordeaux, IMPLANET is a medical technology company that manufactures high-quality implants for orthopedic surgery.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.implanet.com
  • Inc. 60 State Street Suite 700
    Boston, MA USA 02109
  • Phone: N/A

Executives

Name Title Contact Details

Similar Companies

Artio Medical

ARTIO MEDICAL, formerly known as Metactive Medical, is developing innovative endovascular medical devices with the potential to provide immediate and lasting occlusion of aneurysms, blood vessels, and other vascular structures. Artio`s products enable precision placement and provide immediate, complete, and lasting occlusion of target vessel segments and saccular aneurysms. These products will enable physicians to perform better, faster, and safer vascular occlusion procedures.

Sultan Healthcare

Sultan Healthcare is a Hackensack, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Edison First Aid Squad No 2

Edison First Aid Squad No 2 is a Edison, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ZANDER IVF

ZANDER IVF is a Vero Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Armetheon

Armetheon, Inc. is a privately held San Francisco Bay area-based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced biotech entrepreneurs and drug developers. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anti-coagulation and anti-arrhythmia for atrial fibrillation. The company was founded with the idea that drug innovations can happen by building on the success of proven medications. We create solutions that are within the same class of medication and that utilize the same mechanism of action as existing therapies. This development approach has the ability to offer peace of mind to patients while benefitting physicians, who may wish to reduce safety concerns, side effects and adverse events for their patients.